Screener
Inhibrx Biosciences, Inc. INBX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0002007919-26-000027
| Line item | MARCH 31, 2026 | DECEMBER 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 6) | ||
| Stockholders’ equity (deficit) | ||
| Preferred stock, $0.0001 par value; 15,000,000 shares authorized as of March 31, 2026 and December 31, 2025; no shares issued or outstanding as of March 31, 2026 and December 31, 2025. | — | — |
| Common stock, $0.0001 par value; 120,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 14,607,286 shares issued and outstanding as of March 31, 2026 and 14,577,609 shares issued and outstanding as of December 31, 2025. | 1 | 1 |
| Additional paid-in-capital | 258,592 | 254,179 |
| Accumulated deficit | (279,628) | (246,187) |
| Total stockholders’ equity (deficit) | (21,035) | 7,993 |
| Total liabilities and stockholders’ equity (deficit) | $183,967 | $146,478 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Inhibrx Biosciences, Inc.'s total equity?
- Inhibrx Biosciences, Inc. (INBX) reported total equity of -$21.04M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s total equity changed year-over-year?
- Inhibrx Biosciences, Inc.'s total equity decreased by 122.3% year-over-year, from $94.44M to -$21.04M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s total equity?
- Over 3 years (2022 to 2025), Inhibrx Biosciences, Inc.'s total equity has grown at a -48.4% compound annual growth rate (CAGR), from $58.06M to $7.99M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Inhibrx Biosciences, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude